{"id":"https://openalex.org/W190160322","doi":null,"title":"Progression, risk factors and subsequent medical management of symptomatic benign prostatic hyperplasia.","display_name":"Progression, risk factors and subsequent medical management of symptomatic benign prostatic hyperplasia.","publication_year":2009,"publication_date":"2009-03-01","ids":{"openalex":"https://openalex.org/W190160322","mag":"190160322","pmid":"https://pubmed.ncbi.nlm.nih.gov/19499750"},"language":"en","primary_location":{"id":"pmid:19499750","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/19499750","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Archivio italiano di urologia, andrologia : organo ufficiale [di] Societa italiana di ecografia urologica e nefrologica","raw_type":"Journal Article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5101884501","display_name":"Francesco Pinto","orcid":"https://orcid.org/0000-0003-1937-9957","observed_orcids":["https://orcid.org/0000-0003-1937-9957"]},"institutions":[{"id":"https://openalex.org/I103320735","display_name":"Universit\u00e0 Cattolica del Sacro Cuore","ror":"https://ror.org/03h7r5v07","country_code":"IT","type":"education","lineage":["https://openalex.org/I103320735"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Francesco Pinto","raw_affiliation_strings":["Department of Urology, Catholic University School of Medicine, Rome. francesco.pinto@libero.it"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Urology, Catholic University School of Medicine, Rome. francesco.pinto@libero.it","institution_ids":["https://openalex.org/I103320735"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045159633","display_name":"Marco Racioppi","orcid":"https://orcid.org/0000-0001-9129-8479","observed_orcids":["https://orcid.org/0000-0001-9129-8479"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Marco Racioppi","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057093776","display_name":"Emilio Sacco","orcid":"https://orcid.org/0000-0003-4640-8354","observed_orcids":["https://orcid.org/0000-0003-4640-8354"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Emilio Sacco","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062031636","display_name":"Angelo Totaro","orcid":"https://orcid.org/0000-0001-6641-6154","observed_orcids":["https://orcid.org/0000-0001-6641-6154"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Angelo Totaro","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006082780","display_name":"Antonio Brescia","orcid":"https://orcid.org/0000-0003-3820-2866","observed_orcids":["https://orcid.org/0000-0003-3820-2866"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Antonio Brescia","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083554990","display_name":"Andrea Volpe","orcid":"https://orcid.org/0000-0002-4717-6586","observed_orcids":["https://orcid.org/0000-0002-4717-6586"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Andrea Volpe","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058124751","display_name":"Mario Gardi","orcid":"https://orcid.org/0000-0001-5923-9233","observed_orcids":["https://orcid.org/0000-0001-5923-9233"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mario Gardi","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5112478591","display_name":"Pier Francesco Bassi","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Pier Francesco Bassi","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":1.1624,"has_fulltext":false,"cited_by_count":11,"citation_normalized_percentile":{"value":0.79420309,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":96},"biblio":{"volume":"81","issue":"1","first_page":"1","last_page":"8"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10279","display_name":"Urinary Bladder and Prostate Research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2748","display_name":"Urology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10279","display_name":"Urinary Bladder and Prostate Research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2748","display_name":"Urology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10124","display_name":"Prostate Cancer Diagnosis and Treatment","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2748","display_name":"Urology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11232","display_name":"Urinary Tract Infections Management","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2748","display_name":"Urology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/benign-prostatic-hyperplasia","display_name":"benign prostatic hyperplasia","score":1.0},{"id":"https://openalex.org/keywords/disease-progression","display_name":"disease progression","score":0.9470000267028809},{"id":"https://openalex.org/keywords/risk-factors","display_name":"risk factors","score":0.9179999828338623},{"id":"https://openalex.org/keywords/lower-urinary-tract-symptoms","display_name":"lower urinary tract symptoms","score":0.8849999904632568},{"id":"https://openalex.org/keywords/acute-urinary-retention","display_name":"acute urinary retention","score":0.9679999947547913},{"id":"https://openalex.org/keywords/prostate-volume","display_name":"prostate volume","score":0.7960000038146973},{"id":"https://openalex.org/keywords/prostate-specific-antigen","display_name":"prostate-specific antigen","score":0.9480000138282776},{"id":"https://openalex.org/keywords/alpha-blockers","display_name":"alpha-blockers","score":0.9480000138282776},{"id":"https://openalex.org/keywords/tamsulosin","display_name":"tamsulosin","score":0.9229999780654907},{"id":"https://openalex.org/keywords/5alpha-reductase-inhibitors","display_name":"5-alpha reductase inhibitors","score":0.9750000238418579},{"id":"https://openalex.org/keywords/dutasteride","display_name":"dutasteride","score":0.9929999709129333},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.9879999756813049},{"id":"https://openalex.org/keywords/medical-management","display_name":"medical management","score":0.5860000252723694}],"concepts":[{"id":"https://openalex.org/C2780542891","wikidata":"https://www.wikidata.org/wiki/Q418480","display_name":"Tamsulosin","level":3,"score":0.9468587636947632},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.920137345790863},{"id":"https://openalex.org/C2778878792","wikidata":"https://www.wikidata.org/wiki/Q424760","display_name":"Dutasteride","level":4,"score":0.859038770198822},{"id":"https://openalex.org/C2779478474","wikidata":"https://www.wikidata.org/wiki/Q446372","display_name":"Lower urinary tract symptoms","level":4,"score":0.8172194957733154},{"id":"https://openalex.org/C2777562237","wikidata":"https://www.wikidata.org/wiki/Q835051","display_name":"Hyperplasia","level":2,"score":0.6306384801864624},{"id":"https://openalex.org/C2776999253","wikidata":"https://www.wikidata.org/wiki/Q1304270","display_name":"Combination therapy","level":2,"score":0.6258128881454468},{"id":"https://openalex.org/C2779091618","wikidata":"https://www.wikidata.org/wiki/Q1366695","display_name":"Urinary retention","level":2,"score":0.6135576963424683},{"id":"https://openalex.org/C126894567","wikidata":"https://www.wikidata.org/wiki/Q105650","display_name":"Urology","level":1,"score":0.5554766654968262},{"id":"https://openalex.org/C2776235491","wikidata":"https://www.wikidata.org/wiki/Q9625","display_name":"Prostate","level":3,"score":0.5102798938751221},{"id":"https://openalex.org/C2775874879","wikidata":"https://www.wikidata.org/wiki/Q424167","display_name":"Finasteride","level":4,"score":0.5018532276153564},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.46513834595680237},{"id":"https://openalex.org/C2910366748","wikidata":"https://www.wikidata.org/wiki/Q4639645","display_name":"5 Alpha-Reductase Inhibitor","level":5,"score":0.42112237215042114},{"id":"https://openalex.org/C2779951463","wikidata":"https://www.wikidata.org/wiki/Q7268788","display_name":"Quality of life (healthcare)","level":2,"score":0.42046433687210083},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.39159953594207764},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.14582476019859314},{"id":"https://openalex.org/C159110408","wikidata":"https://www.wikidata.org/wiki/Q121176","display_name":"Nursing","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000068538","descriptor_name":"Dutasteride","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000077409","descriptor_name":"Tamsulosin","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000317","descriptor_name":"Adrenergic alpha-Antagonists","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000367","descriptor_name":"Age Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D001378","descriptor_name":"Azasteroids","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D004791","descriptor_name":"Enzyme Inhibitors","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011470","descriptor_name":"Prostatic Hyperplasia","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D011470","descriptor_name":"Prostatic Hyperplasia","qualifier_ui":"Q000175","qualifier_name":"diagnosis","is_major_topic":false},{"descriptor_ui":"D011470","descriptor_name":"Prostatic Hyperplasia","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D011470","descriptor_name":"Prostatic Hyperplasia","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":true},{"descriptor_ui":"D011788","descriptor_name":"Quality of Life","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012307","descriptor_name":"Risk Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013449","descriptor_name":"Sulfonamides","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D014408","descriptor_name":"Biomarkers, Tumor","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D016055","descriptor_name":"Urinary Retention","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017410","descriptor_name":"Practice Guidelines as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017430","descriptor_name":"Prostate-Specific Antigen","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D018450","descriptor_name":"Disease Progression","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018931","descriptor_name":"Antineoplastic Agents, Hormonal","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D019317","descriptor_name":"Evidence-Based Medicine","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D058668","descriptor_name":"Adrenergic alpha-1 Receptor Antagonists","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D058891","descriptor_name":"5-alpha Reductase Inhibitors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:19499750","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/19499750","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Archivio italiano di urologia, andrologia : organo ufficiale [di] Societa italiana di ecografia urologica e nefrologica","raw_type":"Journal Article"},{"id":"mag:190160322","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/19499750","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":50,"referenced_works":["https://openalex.org/W1502297476","https://openalex.org/W1577498128","https://openalex.org/W1970837826","https://openalex.org/W1972230633","https://openalex.org/W1973003445","https://openalex.org/W1976990909","https://openalex.org/W1977909540","https://openalex.org/W1979909194","https://openalex.org/W1981132426","https://openalex.org/W1981707741","https://openalex.org/W1999059326","https://openalex.org/W2007585268","https://openalex.org/W2023503550","https://openalex.org/W2023522825","https://openalex.org/W2024479369","https://openalex.org/W2024709804","https://openalex.org/W2026744183","https://openalex.org/W2037376858","https://openalex.org/W2038448732","https://openalex.org/W2040942287","https://openalex.org/W2041504274","https://openalex.org/W2044530287","https://openalex.org/W2044955709","https://openalex.org/W2045650855","https://openalex.org/W2052982436","https://openalex.org/W2063076766","https://openalex.org/W2064383154","https://openalex.org/W2065009889","https://openalex.org/W2076604782","https://openalex.org/W2092341658","https://openalex.org/W2093173335","https://openalex.org/W2094964957","https://openalex.org/W2105065657","https://openalex.org/W2105391005","https://openalex.org/W2108473469","https://openalex.org/W2113444295","https://openalex.org/W2123351465","https://openalex.org/W2138461535","https://openalex.org/W2149263243","https://openalex.org/W2157973417","https://openalex.org/W2168369822","https://openalex.org/W2237870820","https://openalex.org/W2297358297","https://openalex.org/W2332404609","https://openalex.org/W2398868417","https://openalex.org/W2414967488","https://openalex.org/W2424431709","https://openalex.org/W2426223160","https://openalex.org/W2427815449","https://openalex.org/W2798795107"],"related_works":["https://openalex.org/W2106355635","https://openalex.org/W1974345369","https://openalex.org/W2108847543","https://openalex.org/W1984205884","https://openalex.org/W2509817932","https://openalex.org/W1965225639","https://openalex.org/W155432250","https://openalex.org/W2313538084","https://openalex.org/W2415959386","https://openalex.org/W2042731494"],"abstract_inverted_index":{"Benign":[0],"prostatic":[1],"hyperplasia":[2],"(BPH)":[3],"is":[4,13,70,83,103,179,213],"a":[5,30,97,159,180,194],"chronic":[6],"common":[7],"disease":[8,27],"in":[9,36,149,183,221],"many":[10,24],"men":[11,25],"and":[12,44,57,86,154,158,164,171,178,190,255],"often":[14],"associated":[15,51],"with":[16,29,52,68,203,209],"bothersome":[17],"lower":[18],"urinary":[19,41,152],"tract":[20],"symptoms":[21,224],"(LUTS).":[22],"In":[23],"the":[26,76,84,87,120,215,229,246,260],"presents":[28],"progressive":[31],"course":[32],"that":[33],"can":[34],"result":[35],"complications":[37,108],"such":[38,54],"as":[39,55],"acute":[40],"retention":[42],"(AUR)":[43],"BPH-related":[45,126,165],"surgery.":[46,166],"Several":[47],"factors":[48,251],"have":[49,131],"been":[50,240],"progression":[53,254],"age":[56],"prostate":[58],"volume":[59],"(PV).":[60],"Serum":[61],"prostate-specific":[62],"antigen":[63],"(PSA)":[64],"level,":[65],"closely":[66],"correlated":[67],"PV":[69],"another":[71],"useful":[72],"parameter":[73],"for":[74,92,225,252,259],"determining":[75],"risk":[77,122,161,250],"of":[78,123,156,162,188,235,248,262],"BPH":[79,223,253],"progression.":[80],"Medical":[81],"therapy":[82,102,168,227],"first":[85,216],"most":[88],"frequently":[89],"used":[90,241],"treatment":[91,184,257],"BPH;":[93],"surgical":[94],"treatments":[95],"represent":[96],"second-line":[98],"option":[99,182],"when":[100,107],"medical":[101],"non":[104],"effective":[105],"or":[106,125],"are":[109],"associated.":[110],"Alpha-blockers":[111],"achieve":[112],"rapid":[113],"symptom":[114,201],"relief":[115],"but":[116],"do":[117],"not":[118],"reduce":[119],"overall":[121],"AUR":[124,163],"surgery,":[127],"presumably":[128],"because":[129],"they":[130],"no":[132],"effect":[133],"on":[134,245],"PV.":[135],"5alpha-reductase":[136],"inhibitors":[137],"(5ARIs)":[138],"display":[139],"their":[140],"effectiveness":[141],"at":[142,193],"long":[143],"distance":[144],"decreasing":[145],"PV;":[146],"this":[147],"results":[148],"improved":[150],"symptoms,":[151],"flow":[153],"quality":[155],"life,":[157],"reduced":[160],"Combination":[167,187],"provides":[169],"greater":[170,207],"more":[172],"durable":[173],"benefits":[174],"than":[175,208],"either":[176,210],"monotherapy":[177],"recommended":[181],"guidelines.":[185],"The":[186],"dutasteride":[189],"Tamsulosin":[191],"(CombAT),":[192],"pre-planned":[195],"2-year":[196],"analysis,":[197],"has":[198,239],"shown":[199],"sustained":[200],"improvement":[202],"combination":[204,226],"therapy,":[205],"significantly":[206],"monotherapy.":[211],"CombAT":[212],"also":[214],"study":[217],"to":[218,242],"show":[219],"benefit":[220],"improving":[222],"over":[228],"alpha-blocker,":[230],"tamsulosin,":[231],"from":[232],"9":[233],"months":[234],"treatment.":[236],"PubMed":[237],"database":[238],"identify":[243],"publications":[244],"epidemiology":[247],"BPH,":[249],"drug":[256],"options":[258],"management":[261],"BPH.":[263]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2020,"cited_by_count":3},{"year":2019,"cited_by_count":2},{"year":2015,"cited_by_count":1},{"year":2012,"cited_by_count":2}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}